Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstanbul University

About this trial

This randomized prospective study aims to compare the effects of two target-controlled infusion models, the Schnider and Eleveld models, on anesthetic depth and hemodynamic responses during anesthesia induction in adult patients undergoing spinal surgery.

Patients scheduled for spinal surgery will be randomized into either the Schnider or Eleveld group. Before induction, standard monitoring will be applied, including electrocardiography, peripheral oxygen saturation, invasive arterial blood pressure monitoring, heart rate monitoring, and bispectral index monitoring. Anesthesia induction will be performed with fentanyl 2 mcg/kg, rocuronium 0.6 mg/kg, and propofol administered by target-controlled infusion with an effect-site target concentration of 3 mcg/mL according to the allocated pharmacokinetic model.

Hemodynamic parameters and bispectral index values will be recorded before induction and at the 1st, 3rd, 5th, and 10th minutes after induction. Additional parameters, including time to BIS below 40, time to delta activity, burst suppression duration, total propofol dose during the first 5 minutes, need for additional propofol, hemodynamic response to intubation, vasopressor requirement within the first 10 minutes, and use of esmolol, will also be documented. The primary aim is to evaluate whether the Schnider and Eleveld models differ in terms of induction-related hemodynamic stability and anesthetic depth during the early induction period.

Eligibility criteria

Qualifiers

Patients scheduled for elective spinal surgery under general anesthesia

Patients who will undergo surgery at the Neurosurgery Department of Istanbul University, Istanbul Faculty of Medicine

Patients aged 18 years or older

Patients who provide written informed consent to participate in the study

Disqualifiers

Patients with uncontrolled hypertension

Patients with uncontrolled diabetes mellitus

Patients younger than 18 years of age

Patients who do not provide informed consent to participate in the study

Trial design

Treatments tested in this trial

  • TCI Propofol Injection Models- Eleveld
  • TCI Propofol Injection Schnider

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators